-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Q3 EPS Estimates for AstraZeneca Reduced by Zacks Research
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Investment analysts at Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for shares of AstraZeneca in a report issued on Thursday, February 27th. Zacks Research analyst R. Department now expects that the company will earn $1.15 per share for the quarter, down from their previous […]
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Investment analysts at Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for shares of AstraZeneca in a report issued on Thursday, February 27th. Zacks Research analyst R. Department now expects that the company will earn $1.15 per share for the quarter, down from their previous […]
